Maria Bernabe
Pediatrics · Osage Beach, MONPI 1235138330
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 260 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$602
- Amgen$524
- GSK$444
- Novo Nordisk$367
- Merck$340
- AstraZeneca$272
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,284100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 48 | $602 |
| Amgen | 25 | $524 |
| GSK | 22 | $444 |
| Novo Nordisk | 32 | $367 |
| Merck | 21 | $340 |
| AstraZeneca | 18 | $272 |
| Lilly USA, LLC | 10 | $172 |
| Abbott | 7 | $139 |
| Boehringer Ingelheim | 6 | $108 |
| Amarin Pharma, Inc. | 6 | $97 |
| AbbVie | 3 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $84 |
| Shield Therapeutics Inc | 4 | $70 |
| Pfizer | 4 | $66 |
| Sanofi Pasteur Inc. | 3 | $65 |
| Johnson & Johnson | 4 | $64 |
| Sobi, Inc | 3 | $56 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Eisai Inc. | 3 | $52 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Sunovion Pharmaceuticals Inc. | 2 | $39 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Optinose US, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Advanced Respiratory, Inc | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Genentech USA, Inc. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Dexcom, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Exact Sciences | 1 | $23 |
| Baxter Healthcare | 1 | $20 |
| Sanofi | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Edwards Lifesciences | 1 | $18 |
| Apria Healthcare LLC | 1 | $17 |
| Sarepta Therapeutics, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,284 in reported general payments places this provider in the 95th percentile of 1,306 pediatrics providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate ErMethylphenidate Hcl | 12 | $2,178 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Osage Beach
- Molly FiggemeierSaint Louis$74K
- Terri LuetjenKansas City$57K
- Alexander FaySaint Louis$53K
- Kevin MurphyFlorissant$52K
- Sharon HumistonKansas City$41K
- Nikita RajeKansas City$23K
- Natasha BurgertKansas City$20K
- John GalganiHazelwood$18K
- Natalie GoedekerSaint Louis$17K
- Jodi ShrobaKansas City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.